SanBio Co Stock

SanBio Co PEG

PEG Ratio (Price/Earnings-to-Growth) of SanBio Co (4592.T) as of Aug 5, 2026.

PEG

0.00

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of SanBio Co is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of SanBio Co was 2025 -0.43 . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) SanBio Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s SanBio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SanBio Co

All Key Metrics — SanBio Co